Xencor, Inc.
LAG-3 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15RA Fc-FUSION PROTEINS AND LAG-3 ANTIGEN BINDING DOMAINS
Last updated:
Abstract:
The present invention is directed to novel targeted heterodimeric fusion proteins comprising an IL-15/IL-15R.alpha. Fc-fusion protein and a LAG-3 antibody fragment-Fc fusion protein.
Status:
Application
Type:
Utility
Filling date:
18 Apr 2019
Issue date:
21 Nov 2019